None listed
Conditions
Interventions
Intervention1: Dose: 4.5 g/ each dose
Route: intra venous
Total doses: 9 doses: one pre operative, one intra operative and seven post operative
Interval between 2 doses : 8 hours: Piperacillin + Tazob
Sponsors
Institute of liver and biliary sciences
Eligibility
Inclusion criteria
Inclusion criteria: All patient undergoing donor hepatectomy consent for the study
Exclusion criteria
Exclusion criteria: Patients refusing consent for inclusion in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of infective complications (CDC guidelines) in post operative period will be compared among patients receiving 3 doses vs patients receiving 9 doses of antibiotics.Timepoint: Post op day 7 and 15 (Study duration 1 year) | — |
Secondary
| Measure | Time frame |
|---|---|
| Risk factors associated with infective complications will be evaluated in patients undergoing donor hepatectomy. Risk factors will be evaluated as per risk factor assessment proforma. Risk factors to be evaluated are: Pre- Operative Age Gender Liver attenuation index Intra- Operative factors: Duration of surgery Type of graft Volume of graft Volume of remnant liver Blood Loss Blood Transfusion Post - operative factors: Days of hospital stay Timepoint: Post op day 7 and 15 (Study duration 1 year) | — |
Countries
India
Contacts
Public ContactSahil Gupta
Institute of liver and biliary sciences
Outcome results
None listed